Thorax · 1995 · 80 citations · 14 references
Life SciencesBiochemistryMolecular BiologyNucleic Acid BiochemistryPulmonary Drug DeliveryPulmonary Function TestingCystic FibrosisInhalation Drug DeliveryNucleic Acid DeliveryRespiratory DiseaseBronchial SecretionsColorimetric TestsCystic Fibrosis Lung DiseaseDnase TherapyTracheal Secretions
BACKGROUND: The clinical benefit of the administration of aerosolised recombinant human DNase (rhDNase) on pulmonary function in patients with cystic fibrosis has already been demonstrated but the biochemical action of rhDNase on DNA in bronchial secretions in vivo has not yet been investigated. METHODS: Sputum was collected from 135 patients with cystic fibrosis before and during treatment with aerosolised rhDNase and examined to ascertain DNA concentration and length by colorimetric assay and densitometry of gel separated DNA. RESULTS: Treatment with rhDNase reduced the concentration and the size of extracellular DNA in the sputum. The median interquartile range of DNA length decreased from 0.5-2.6 kbp before treatment to 0.3-1.0 kbp during treatment. CONCLUSIONS: rhDNase was delivered to the secretions and was enzymatically active in vivo.
14
The Metabolic Basis of Inherited Disease
Annals of Internal Medicine · 1990 · 4K citations
Henry J. Fuchs, Drucy Borowitz, David Høyrup Christiansen et al. · New England Journal of Medicine · 1994 · 1.5K citations · Full text